FindTrial
Sign In

An open-label study of TAK-536 in patients with grade III hypertension

An open-label study of TAK-536 in patients with grade III hypertension

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220836
Enrollment
Unknown
Registered
2009-09-01
Start date
2009-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

investigational material(s) Generic name etc : TAK-536 INN of investigational material : Therapeutic category code : 214 Antihypertensives Dosage and Administration for Investigational material : Onc

Sponsors

Takeda Pharmaceutical Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Grade III hypertension, etc.

Exclusion criteria

Exclusion criteria: 1.Hypertensive emergency or renovascular hypertension 2.Cardiac disease, cerebrovascular disorder, vascular disease, or advanced hypertensive retinopathy 3.Hyperkalemia, etc.

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026